452 related articles for article (PubMed ID: 23597411)
1. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
Hahné SJ; Veldhuijzen IK; Wiessing L; Lim TA; Salminen M; Laar Mv
BMC Infect Dis; 2013 Apr; 13():181. PubMed ID: 23597411
[TBL] [Abstract][Full Text] [Related]
2. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
[TBL] [Abstract][Full Text] [Related]
3. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
Nelson PK; Mathers BM; Cowie B; Hagan H; Des Jarlais D; Horyniak D; Degenhardt L
Lancet; 2011 Aug; 378(9791):571-83. PubMed ID: 21802134
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.
Bao Y; Larney S; Peacock A; Colledge S; Grebely J; Hickman M; Degenhardt L; Leung J
Int J Drug Policy; 2019 Aug; 70():87-93. PubMed ID: 31125802
[TBL] [Abstract][Full Text] [Related]
6. Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study.
Trickey A; Bivegete S; Duffell E; McNaughton AL; Nerlander L; Walker JG; Fraser H; Hickman M; Vickerman P; Brooks-Pollock E; Christensen H
BMC Infect Dis; 2023 Jul; 23(1):457. PubMed ID: 37430220
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) infections among undocumented migrants and uninsured legal residents in the Netherlands: A cross-sectional study, 2018-2019.
Klok S; van Dulm E; Boyd A; Generaal E; Eskander S; Joore IK; van Cleef B; Siedenburg E; Bruisten S; van Duijnhoven Y; Tramper-Stranders G; Prins M
PLoS One; 2021; 16(10):e0258932. PubMed ID: 34714867
[TBL] [Abstract][Full Text] [Related]
9. Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis.
Syangbo A; Hickman M; Colledge-Frisby S; Leung J; Grebely J; Larney S; Degenhardt L; Trickey A
Drug Alcohol Rev; 2023 Mar; 42(3):569-581. PubMed ID: 36600489
[TBL] [Abstract][Full Text] [Related]
10. Decentralised same day test and treatment of hepatitis C levering existing peer support networks among men who inject drugs: feasibility and effectiveness.
Rajkumar N; Khumukcham LS; Thangjam D; Singh S; Khwairakpam G; Shilton S; Goel A
Harm Reduct J; 2024 May; 21(1):98. PubMed ID: 38769517
[TBL] [Abstract][Full Text] [Related]
11. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.
Khatib A; Matiko E; Khalid F; Welty S; Ali A; Othman A; Haji S; Dahoma M; Rutherford G
BMC Public Health; 2017 Nov; 17(1):917. PubMed ID: 29183287
[TBL] [Abstract][Full Text] [Related]
12. HBV and HCV serological monitoring among injection drugs users in opiate substitution treatment in Bosnia and Herzegovina.
Skocibusic S; Martinac M; Arapovic J; Grgic S; Nikolic J; Hasanagic D; Bevanda M; Ravlija J
J Infect Dev Ctries; 2016 Sep; 10(9):968-972. PubMed ID: 27694729
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of HCV testing approaches in low and middle income countries.
Morgan JR; Servidone M; Easterbrook P; Linas BP
BMC Infect Dis; 2017 Nov; 17(Suppl 1):697. PubMed ID: 29143681
[TBL] [Abstract][Full Text] [Related]
14. Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis.
Rashti R; Alavian SM; Moradi Y; Sharafi H; Mohamadi Bolbanabad A; Roshani D; Moradi G
Arch Virol; 2020 Sep; 165(9):1947-1958. PubMed ID: 32617764
[TBL] [Abstract][Full Text] [Related]
15. Findings from integrated behavioral and biologic survey among males who inject drugs (MWID) - Vietnam, 2009-2010: evidence of the need for an integrated response to HIV, hepatitis B virus, and hepatitis C virus.
Nadol P; O'connor S; Duong H; Le LV; Thang PH; Tram TH; Ha HT; Mcconnell MS; Partridge J; Kaldor J; Law M; Nguyen TA
PLoS One; 2015; 10(2):e0118304. PubMed ID: 25692469
[TBL] [Abstract][Full Text] [Related]
16. A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?
Leung J; Peacock A; Colledge S; Grebely J; Cunningham EB; Hickman M; Vickerman P; Stone J; Trickey A; Dumchev K; Lynskey M; Hines L; Griffiths P; Mattick RP; Degenhardt L; Larney S
J Infect Dis; 2019 Jun; 220(1):78-90. PubMed ID: 30726973
[TBL] [Abstract][Full Text] [Related]
17. HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.
Ray Saraswati L; Sarna A; Sebastian MP; Sharma V; Madan I; Thior I; Pulerwitz J; Tun W
BMC Public Health; 2015 Jul; 15():726. PubMed ID: 26223866
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update.
Han R; Zhou J; François C; Toumi M
BMC Infect Dis; 2019 Jul; 19(1):655. PubMed ID: 31337339
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of hepatitis B, C and D in Malawi: systematic review.
Stockdale AJ; Mitambo C; Everett D; Geretti AM; Gordon MA
BMC Infect Dis; 2018 Oct; 18(1):516. PubMed ID: 30314448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
